Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial

Autor: Moses, Jeffrey W., Nikolsky, Eugenia, Mehran, Roxana, Cambier, Patrick A., Bachinsky, William B., Leya, Fred, Kuntz, Richard E., Popma, Jeffrey J., Schleckser, Patricia, Wang, Hong, Cohen, Sidney A., Leon, Martin B.
Zdroj: In The American Journal of Cardiology 2006 98(11):1455-1460
Databáze: ScienceDirect
Externí odkaz: